Synthomer (LON:SYNT) Releases Earnings Results

Synthomer (LON:SYNTGet Free Report) announced its quarterly earnings data on Wednesday. The company reported GBX (3.50) (($0.05)) EPS for the quarter, Digital Look Earnings reports. Synthomer had a negative net margin of 4.40% and a negative return on equity of 7.52%.

Synthomer Stock Performance

LON SYNT traded up GBX 5.80 ($0.08) during trading on Friday, reaching GBX 120.20 ($1.56). The company’s stock had a trading volume of 1,572,302 shares, compared to its average volume of 657,878. The company has a current ratio of 1.90, a quick ratio of 0.97 and a debt-to-equity ratio of 78.27. The firm has a market capitalization of £197.10 million, a price-to-earnings ratio of -2.41, a price-to-earnings-growth ratio of -0.17 and a beta of 1.79. Synthomer has a 12 month low of GBX 114 ($1.48) and a 12 month high of GBX 338 ($4.38). The firm has a 50 day moving average price of GBX 139.90 and a 200 day moving average price of GBX 171.16.

Wall Street Analyst Weigh In

Separately, Berenberg Bank downgraded shares of Synthomer to a “hold” rating and reduced their target price for the stock from GBX 230 ($2.98) to GBX 150 ($1.94) in a report on Wednesday.

Read Our Latest Stock Report on Synthomer

About Synthomer

(Get Free Report)

Synthomer plc operates as a specialty chemicals company in the United Kingdom and internationally. It operates through five segments: Performance Elastomers, Functional Solutions, Industrial Specialities, Acrylate Monomers, and Adhesive Technologies. The company offers adhesives, including PSA labels, packaging and specialty tapes, saturants, release coatings, wood working, wet glues, hygiene and contact adhesives, packaging and assembly hot melt adhesives; coatings products such as architectural, masonry, intumescent, metal, wood, soil releases, blinders, ink receptive, polyester for powder coatings, SYNTHOMER NX for coalescing agents, and SYNOLOX BEPF for glycol.

Read More

Receive News & Ratings for Synthomer Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synthomer and related companies with MarketBeat.com's FREE daily email newsletter.